Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

Laser and light treatments can effectively remove hair long-term.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Some therapies using stem cells and platelet-rich plasma may help treat osteoarthritis, but more research is needed to ensure they are safe and effective.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Fermented papaya and mangosteen in hair care products helped prevent hair loss and improve hair thickness.

Creating fully functional artificial skin for chronic wounds is still very challenging.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Plasma-activated liquid can kill harmful cells, speed up wound healing, and potentially treat cancer without damaging healthy cells.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Using both minoxidil and platelet-rich plasma therapy together is more effective for hair growth in women than using minoxidil alone.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.